feed,title,long_url,short_url
Benzinga,Encouraging Data From Seagen/Genmab's Cervical Cancer Study - Tivdak Success Sets Stage For New Indications,https://benzinga.com/analyst-ratings/analyst-color/23/09/34231181/encouraging-data-from-seagengenmabs-cervical-cancer-study-tivdak-success-sets-stage,https://da.gd/oFNjGZ
